IL-PROJECT44
30.4.2021 15:02:11 CEST | Business Wire | Press release
project44, the global leader in advanced visibility for shippers and logistics service providers will expand its real-time shipment tracking services in China – giving clients the same transportation visibility it offers across mature markets like North American and Europe. This expansion will focus the company’s resources on Asia-based visibility to fulfill its vision for global end-to-end visibility across all modes of transportation.
With logistics events in Asia continuing to send shockwaves across western markets, the opacity of Asia’s trucking markets has emerged as a weak link in global supply chains. As the economic recovery picks up pace, global supply chains are under pressure to improve agility, predictability, and efficiency.
At the same time, truckload markets in Asia have been modernizing rapidly as old trucks go out of service and China continues to incentivize the scrapping of old trucks. Newer trucks are equipped with electronic logging devices, paving the way to connect these trucks (with necessary data privacy provisions) to supply chain networks. These developments allow project44 to provide the foundational data needed to translate early indicators into important levers for supply chain resiliency.
Industry Support
The move by project44 to ramp up visibility in China has garnered broad support across the industry:
“Over the past year, Gartner has seen a dramatic increase in interest for Real-Time Transportation Visibility (RTTV) in the Asia Pacific,” said Bart A. De Muynck, Research Vice President, Transportation Technology at Gartner. “The sheer size of the Asia Pacific region combined with the diverse cultures spread across it creates unique challenges for transportation. Organizations that operate complex global supply chains often favor visibility solutions that can be implemented and utilized worldwide. project44 is recognized as a Leader by Gartner for its strong presence in both North America and Europe. Enterprise shippers that operate in Asia will benefit from project44’s expanded carrier coverage in China.”
“Building a more predictable global supply chain to increase on-time delivery and customer satisfaction is key to Lenovo’s business strategy,” said Renée Ure, Chief Operating Officer, Lenovo Infrastructure Solutions Group. “It’s critical to understand when materials are arriving from our suppliers to our factories across the world. project44’s expansion into the Asia Pacific region will give us further end-to-end visibility into our global supply chain to help us deliver on our promises to our customers.”
"CNHi is a truly global company in 180 countries. The recent state of global transportation has proven challenging, in part because it is difficult to manage our supply chains that span so many countries when disruption is high and visibility is so fragmented," said Dror Noach, Vice President of Global Logistics, CNH Industrial. "Gaining better visibility of both domestic and inbound flows going into our Asian manufacturing plants, especially China, could be quite beneficial for us. We believe project44's efforts to expand coverage in this region can help us improve assurance of supply and increase our efficiency."
Expanded Global Network Coverage
project44's best-in-class network already connects truckload carriers on every continent and nearly all containerized ocean freight moving between them, however, getting visibility into Asia’s trucking market remains a challenge for shippers. Its increased focus on Asian markets allows project44 to increase saturation outside of mature transportation markets and into Asia's ground transportation networks.
“At project44 we want to be wherever our customers need us, which means being connected to carriers all over the globe. For the first time ever, shippers can have a true global view of their supply chain network in a single platform,” said Jett McCandless, CEO and Founder of project44. “With our expansion into the Asia Pacific, we are considering the capabilities, regulations, and intricacies within each country which is key to delivering value to our current and future customers."
By expanding visibility in Asian markets, project44 will help buyers of Asian goods increase the resiliency of their supply chains. And in the process, project44 will extend visibility to domestic Asian shippers and logistics service providers who demand the same real-time transportation visibility enjoyed in western markets.
About project44
project44 solves some of the world’s most critical logistics challenges by connecting, automating, and providing real-time visibility into global transportation processes. With project44’s cloud-based platform, organizations can increase operational efficiencies, reduce costs, improve shipping performance, and deliver an exceptional, Amazon-like experience to their customers. project44 supports all transportation modes and shipping types, including air, parcel, final-mile, less-than-truckload, volume less-than-truckload, groupage, truckload, rail, intermodal, and ocean. To learn more, visit www.project44.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210430005100/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation5.8.2026 15:37:00 CEST | Press release
The new SpeechLive Legal AI Assistant reduces the administrative burden on legal professionals through customizable document drafting powered by speech recognition tuned for legal terminology Speech Processing Solutions, the global leader in AI-assisted professional dictation and documentation solutions sold under the Philips brand, today announced the Philips SpeechLive Legal AI Assistant. The new solution transforms voice recordings, dictation and uploaded sources into structured, ready-to-review legal documents, helping legal professionals work faster while retaining control of the final draft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805997413/en/ The new Philips SpeechLive Legal AI Assistant is designed for turning conversations into ready-to-review legal document drafts. SpeechLive Legal significantly reduces the time needed to transform voice input into structured legal documentation, delivering consistent an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
